PURE Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-6.3M | $-14.4M | $-7.6M | $-11.1M | $-7.7M | $-8.9M | $-8.3M |
| Depreciation & Amortization | $276.0K | $219.0K | $206.0K | $248.0K | $311.0K | $385.0K | $471.0K |
| Depreciation | $98.0K | $40.0K | $27.0K | $71.0K | $123.0K | $179.0K | $285.0K |
| Amortization | $178.0K | — | $179.0K | $177.0K | $188.0K | $206.0K | $186.0K |
| Stock-Based Compensation | $1.1M | $1.9M | $2.4M | $3.0M | $720.0K | $1.1M | $1.2M |
| Net Cash from Operating Activities | $-4.6M | $-5.0M | $-6.1M | $-6.3M | $-3.9M | $-5.6M | $-6.1M |
| Investing Activities | |||||||
| Capital Expenditures | $206.0K | $390.0K | $81.0K | $21.0K | $12.0K | $10.0K | $14.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-226.0K | $-405.0K | $-107.0K | $-46.0K | $-231.0K | $-249.0K | $-244.0K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.2M | $9.3M | $7.4M | $6.4M | $3.3M | $4.9M | $6.0M |
| Net Change in Cash | $-3.6M | $3.9M | $1.2M | $54.0K | $-845.0K | $-917.0K | $-399.0K |
| Free Cash Flow | $-4.8M | $-5.4M | $-6.1M | $-6.3M | $-3.9M | $-5.6M | $-6.1M |